MRC1+ subset also showed a M2-like phenotype with high expression of MRC1 (CD206), CSF1R, and TGFB1, and enriched in some AML patients, such as AML210A, AML707B, and AML921. This evidence concerns the gene MRC1 and acute myeloid leukemia.